Overall, the trend remains positive, though some consolidation cannot be ruled out. Below are some short-term trading ideas ...
An engineered triphasic biomaterial scaffold successfully recreated the cranial suture stem cell niche lost in ...
Morning Overview on MSN
The first cellular age-reversal therapy has been cleared for human trials
Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results